共 193 条
[1]
Andratschke N(2022)European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making Lancet Oncol 23 e469-e78
[2]
Willmann J(1995)Surveillance or Metastasis-Directed therapy for oligometastatic prostate Cancer recurrence: a prospective, randomized, Multicenter Phase II Trial J Clin oncology: official J Am Soc Clin Oncol 13 8-10
[3]
Appelt AL(2018)Stereotactic ablative radiotherapy for the Comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial J Clin oncology: official J Am Soc Clin Oncol 36 446-53
[4]
Alyamani N(2020)Outcomes of Observation vs Stereotactic Ablative Radiation for oligometastatic prostate Cancer: the ORIOLE phase 2 Randomized Clinical Trial J Clin oncology: official J Am Soc Clin Oncol 38 2830-8
[5]
Balermpas P(2020)Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study JAMA Oncol 6 650-9
[6]
Baumert BG(2016)Local therapy for Oligoprogressive Disease in patients with Advanced Stage non-small-cell Lung Cancer harboring epidermal growth factor receptor mutation Lancet Oncol 17 1672-82
[7]
Hellman S(2017)Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: dose and site of metastases matter Clin Lung Cancer 18 e369-e73
[8]
Weichselbaum RR(2020)Stereotactic radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients receiving tyrosine kinase inhibitor therapy: a phase 2 prospective Multicenter Study Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 142 236-45
[9]
Oligometastases P(2021)SMART ablation of lymphatic oligometastases in the pelvis and abdomen: clinical and dosimetry outcomes Eur Urol 80 693-700
[10]
Ost D(2022)Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate Cancer nodal recurrences Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 168 106-12